Agilent Technologies (A) : Investors lapped up stocks on upticks to the tune of $6.61 million in the Mondays trading session. The trading value on downticks was comparatively at $4.94 million and the uptick to downtick ratio of 1.34 indicates continuous buying by the bulls. The net money flow into the stock was $1.67 million. The block trades were dominated by the bulls with a healthy 2.72, uptick to downtick ratio. Only $1.23 million worth of trades exchanged hands on downticks showing the reluctance of the large traders to part with their holdings. Upticks saw transactions worth $3.33 clearly indicating buying by large investors. The total money flow for block trades stood at $2.11 million, which is a positive for the stock in the long-term. Agilent Technologies (A) fell $0.04 during the day at $46.64, a drop of -0.07% over the previous days close. However, for the week, the stock is 2.54%, compared to the previous week.
Agilent Technologies, Inc. is up 13.59% in the last 3-month period. Year-to-Date the stock performance stands at 12.55%. Shares of Agilent Technologies, Inc. rose by 3.08% in the last five trading days and 3.42% for the last 4 weeks. In a related news,The director of Agilent Technologies Inc, Cullen James sold 16,697 shares at $45.78 on May 27, 2016. The Insider selling transaction had a total value worth of $764,389. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Agilent Technologies (NYSE:A): stock turned positive on Monday. Though the stock opened at $46.6, the bulls momentum made the stock top out at $46.875 level for the day. The stock recorded a low of $46.341 and closed the trading day at $46.8, in the green by 0.28%. The total traded volume for the day was 1,362,884. The stock had closed at $46.67 in the previous days trading.
Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.